Literature DB >> 31522232

LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.

Ivan Castellví1, Saioa Eguiluz2, Alejandro Escudero-Contreras3, Juan José Ríos4, Jaime Calvo-Alén5, José Luis Callejas-Rubio6, Carlos De la Puente7, Carmen Pilar Simeón8, Francisco Javier Narváez9, Gerard Espinosa10, Patricia E Carreira11, Manuel Rubio-Rivas12, Juan José Alegre13, Alfredo Guillén-Del-Castillo8, Jose Andrés Román-Ivorra14, Vicent Fonollosa8.   

Abstract

The objective of this study was to evaluate the impact of digital ulcers (DUs) in daily life of systemic sclerosis (SSc) Spanish patients. We developed a multicenter observational study to compare functional disability in SSc patients with active DUs vs. those without DUs. An additional correlation between perception of patients and physicians on disability due to DUs was performed. A total of 199 patients were enrolled, 70 (35%) with DUs. Patients with DUs were younger (48 vs. 58 years; p < 0.001) and had more frequently the diffuse subtype of SSc (45 vs. 24%; p = 0.004) than patients without DUs. Patients with DUs showed significantly higher scores in the Cochin Hand Function Scale overall (p < 0.002) and for each of its five dimensions. They also showed higher scores in the Systemic Sclerosis Health Assessment Questionnaire items related to hand function such as, dress and self-care (p < 0.013), eat (p < 0.013) and grip (p < 0.03), and higher Visual Analogic Scale scores for pain (p < 0.013), trouble related with Raynaud's Phenomenon (p < 0.001) and sense of severity (p < 0.004). Impact on daily activities was significantly higher in patients with DUs (p = 0.002), with a non-significant trend to experience higher impact on work productivity (p = 0.07). A high correlation was found between DUs patients and physicians opinion on the impact of DUs (daily life: Pearson R = 0.86; work productivity: Pearson R = 0.87). Study findings show an impaired hand function and increased disability for daily life activities and work productivity in SSc patients with DUs compared with patients without DUs in Spanish population.

Entities:  

Keywords:  Disability evaluation; Hand; Human activities; Quality of life; Scleroderma and related disorders

Mesh:

Year:  2019        PMID: 31522232     DOI: 10.1007/s00296-019-04436-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.

Authors:  S Maddali-Bongi; A Del Rosso; S Mikhaylova; B Francini; A Branchi; M Baccini; M Matucci-Cerinic
Journal:  Clin Exp Rheumatol       Date:  2014-05-21       Impact factor: 4.473

2.  The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties.

Authors:  Sindhu R Johnson; Gillian A Hawker; Aileen M Davis
Journal:  Arthritis Rheum       Date:  2005-04-15

3.  Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis.

Authors:  S Poiraudeau; X Chevalier; T Conrozier; R M Flippo; F Lioté; E Noël; M M Lefevre-Colau; J Fermanian; M Revel; R Rhumato
Journal:  Osteoarthritis Cartilage       Date:  2001-08       Impact factor: 6.576

4.  Discordance between patient and physician assessments of disease severity in systemic sclerosis.

Authors:  Marie Hudson; Ann Impens; Murray Baron; James R Seibold; Brett D Thombs; Jennifer G Walker; Russell Steele
Journal:  J Rheumatol       Date:  2010-09-15       Impact factor: 4.666

5.  Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.

Authors:  François Rannou; Serge Poiraudeau; Alice Berezné; Thierry Baubet; Véronique Le-Guern; Jean Cabane; Loïc Guillevin; Michel Revel; Jacques Fermanian; Luc Mouthon
Journal:  Arthritis Rheum       Date:  2007-02-15

6.  Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.

Authors:  A Bérezné; R Seror; S Morell-Dubois; M de Menthon; E Fois; A Dzeing-Ella; C Nguyen; E Hachulla; L Guillevin; S Poiraudeau; L Mouthon
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-02       Impact factor: 4.794

7.  Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.

Authors:  Luc Mouthon; Patrick H Carpentier; Catherine Lok; Pierre Clerson; Virginie Gressin; Eric Hachulla; Alice Bérezné; Elisabeth Diot; Aurélie Khau Van Kien; Patrick Jego; Christian Agard; Anne Bénédicte Duval-Modeste; Agnès Sparsa; Eve Puzenat; Marie-Aleth Richard
Journal:  J Rheumatol       Date:  2014-06-15       Impact factor: 4.666

8.  Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.

Authors:  S I Nihtyanova; G M Brough; C M Black; C P Denton
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

9.  Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

Authors:  Peter A Merkel; Karen Herlyn; Richard W Martin; Jennifer J Anderson; Maureen D Mayes; Patrice Bell; Joseph H Korn; Robert W Simms; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jiménez; Barbara White; James R Seibold; Fredrick M Wigley
Journal:  Arthritis Rheum       Date:  2002-09

10.  Digital ischemia in scleroderma spectrum of diseases.

Authors:  Elena Schiopu; Ann J Impens; Kristine Phillips
Journal:  Int J Rheumatol       Date:  2010-08-31
View more
  1 in total

1.  Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population.

Authors:  Ling Xiang; Sandra M Y Kua; Andrea H L Low
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-12       Impact factor: 5.178

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.